Suzhou Techfields Pharma

Suzhou Techfields Pharma is a clinical-stage biopharmaceutical company focused on the development of innovative drugs using its proprietary Functional Prodrug technology. The company specializes in creating prodrug versions of well-established therapeutic agents to improve their solubility, permeability, and overall bioavailability, particularly for transdermal and topical delivery. Its lead programs include advanced clinical candidates for the treatment of inflammatory conditions such as osteoarthritis and rheumatoid arthritis. By leveraging its platform, Techfields aims to reduce systemic side effects and enhance the efficacy of existing small molecule drugs across various therapeutic areas, including cardiovascular health and dermatology.